Liu H, Xu W, Xiong Y, Zhang J, Luo D, Wu J
Acta Orthop Belg. 2024 Sep;90(3):559-565. doi: 10.52628/90.3.12760.
Distal tibial fractures are common lower-limb injuries and are generally associated with a high risk of postoperative complications, especially in patients with multiple medical comorbidities. This study sought to ascertain the efficacy of retrograde intramedullary tibial nails (RTN) for treating extra-articular distal tibial fractures in high-risk patients. Between January 2019 and December 2021, 13 patients considered at high risk for postoperative complications underwent RTN fixation. Comorbidities in the patient sample included diabetes, renal disease, hypertension, severe osteoporosis, hemorrhagic blisters, long-term smoking, alcoholism and so on. Medical records were retrospectively reviewed to assess treatment data, wound complications, infections, hardware failure, time to bone union, and functional outcomes. The mean preoperative waiting time and operation duration was 7.1 ± 1.7 days and 61.1 ± 7.1 minutes, respectively. The hospital stay time ranged from 10 to 16 days, with a mean of 12.6 ± 1.9 days. All patients were monitored for a mean follow-up time of 17.5 ± 3.3 months. All patients achieved fracture union with an average healing time of 5.0 ± 0.7 months. No implant failure or persistent pain was observed in the surgical site. Two patients had superficial infection, but no further complications resulted from the incision. At the final follow-up, the average AOFAS score was 84.0 ± 7.3 points, with an excellent and good rate of 76.9%. RTN appears to be a reliable treatment option for extra-articular distal tibial fractures in high-risk patients.
胫骨远端骨折是常见的下肢损伤,通常术后并发症风险较高,尤其是在患有多种内科合并症的患者中。本研究旨在确定逆行髓内胫骨髓内钉(RTN)治疗高危患者关节外胫骨远端骨折的疗效。在2019年1月至2021年12月期间,13例被认为术后并发症风险高的患者接受了RTN固定。患者样本中的合并症包括糖尿病、肾病、高血压、严重骨质疏松、出血性水泡、长期吸烟、酗酒等。对病历进行回顾性分析,以评估治疗数据、伤口并发症、感染、内固定失败、骨愈合时间和功能结果。术前平均等待时间和手术时长分别为7.1±1.7天和61.1±7.1分钟。住院时间为10至16天,平均为12.6±1.9天。所有患者平均随访17.5±3.3个月。所有患者均实现骨折愈合,平均愈合时间为5.0±0.7个月。手术部位未观察到内固定失败或持续疼痛。2例患者发生浅表感染,但切口未引发进一步并发症。在末次随访时,平均美国足踝外科协会(AOFAS)评分为84.0±7.3分,优良率为76.9%。对于高危患者的关节外胫骨远端骨折,RTN似乎是一种可靠的治疗选择。